(79 days)
Not Found
No
The summary describes a standard hematology analyzer and does not mention any AI or ML capabilities, image processing, or training/test sets typically associated with such technologies.
No
This device is an in vitro diagnostic hematology analyzer used in clinical laboratories to count and differentiate blood cells. It is used for diagnosis and monitoring, not for treating a disease or condition.
Yes
Explanation: The "Intended Use / Indications for Use" section explicitly states "for in vitro diagnostic use in clinical laboratories."
No
The device description explicitly states it is a "hematology analyzer with autoloader and external computer workstation," indicating it includes hardware components beyond just software.
Yes, this device is an IVD (In Vitro Diagnostic).
The "Intended Use / Indications for Use" section explicitly states:
"The COULTER® AcT™ 5diff Autoloader (AL) hematology analyzer is a quantitative, automated hematology analyzer and leukocyte differential counter for in vitro diagnostic use in clinical laboratories."
This statement clearly indicates that the device is intended for use in diagnosing conditions by examining samples outside of the body (in vitro), which is the definition of an IVD.
N/A
Intended Use / Indications for Use
The COULTER® AcT™ 5diff Autoloader (AL) hematology analyzer is a quantitative, automated hematology analyzer and leukocyte differential counter for in vitro diagnostic use in clinical laboratories.
The COULTER® AcT™ 5diff Autoloader (AL) hematology analyzer is a 26parameter, fully automated hematology analyzer, including a five-part leukocyte differential counter, capable of analyzing samples in a closed-vial Autoloader mode or a Manual (Stat) mode (open- or closed-vial).
An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cvtometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.
Product codes (comma separated list FDA assigned to the subject device)
GKZ
Device Description
The COULTER® AcT™ 5diff Autoloader (AL) is a moderate cost 5-part differential hematology analyzer with autoloader and external computer workstation.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
blood, bone marrow, or other body fluids.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
clinical laboratories
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence studies of the COULTER® AcT 5diff AL Hematology Analyzer to products already in commercial distribution.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 864.5220 Automated differential cell counter.
(a)
Identification. An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.(b)
Classification. Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”
0
K03029/
Summary of Safety & Effectiveness COULTER® AcT™ 5diff Autoloader (AL)
1.0 Submitted By:
APR 1 7 2003
Lourdes Coba Senior Regulatory Affairs Specialist Beckman Coulter, Inc. 11800 SW 147 Avenue, M/C: 31-B06 Miami, Florida 33196-2500 Telephone: (305) 380-4079 FAX: (305) 380-3618
2.0 Date Submitted:
January 27, 2003
3.0 Device Name(s):
3.1 Proprietary Names
COULTER® AcT™ 5diff Autoloader (AL)
3.2 Classification Name
Automated Differential Cell Counter (21 CFR § 864.5220)
4.0 Predicate Device:
| Candidate(s) | Predicate #1 | Manufacturer | Docket Number |
|---|---|---|---|
| COULTER® AcT TM 5diff | |||
| Autoloader (AL) | COULTER® HmX with | ||
| Autoloader | Beckman Coulter, Inc. | K922704/A1 | |
| CELL-DYN® 4000* | Abbott Diagnostics** | K961439 |
- Trademark of Abbott Diagnostics
** Abbott Diagnostics, 5440 Patrick Henry Drive, Santa Clara, CA.
1
5.0 Description:
The COULTER® AcT™ 5diff Autoloader (AL) is a moderate cost 5-part differential hematology analyzer with autoloader and external computer workstation.
6.0 Intended Use:
The COULTER® AcT™ 5diff Autoloader (AL) hematology analyzer is a quantitative, automated hematology analyzer and leukocyte differential counter for in vitro diagnostic use in clinical laboratories.
Clinical Significance:
The purpose of the AcT 5diff AL is to separate the normal patient, with all normal system-generated parameters from the patient who needs additional studies of any of these parameters. These studies might include further measurements of cell size, and or distribution, biochemical investigations, manual WBC differential or any other derivative test that helps diagnosis of the patient's condition.
7.0 Comparison to Predicate(s):
COULTER® AcT™ 5diff Autoloader (AL) is substantially equivalent to theBeckman Coulter HmX with Autoloader and the Abbott CELL-DYN 4000.
| Predicate Device (1) | Predicate Device (2) | Device | |
|---|---|---|---|
| Beckman Coulter | |||
| HmX with Autoloader | Abbott | ||
| CELL-DYN CD4000 | Beckman Coulter | ||
| A°•T 5diff AL | |||
| Parameters | 24 | 28 | 26 |
| WBC, RBC, Hgb, Hct, | WBC, RBC, Hgb, Hct, | WBC, RBC, Hgb, Hct, | |
| MCV, MCH, MCHC, | MCV, MCH, MCHC, | MCV, MCH, MCHC, | |
| RDW, Plt, MPV, PDW*, | RDW, Plt, MPV, PDW*, | RDW, Plt, MPV, PDW*, | |
| Pct*, | Pct*, WBC Viable | Pct*, | |
| Lymphocyte % & #, | Fraction*, NRBC #, | Lymphocyte % & #, | |
| Monocyte % & # | NRBC / 100 WBC | Monocyte % & # | |
| Neutrophil % & # | Lymphocyte % & #, | Neutrophil % & # | |
| Eosinophil % & # | Monocyte % & # | Eosinophil % & # | |
| Basophil % & # | Neutrophil % & # | Basophil % & # | |
| Eosinophil % & # | Atypical Lymph % & # * | ||
| Basophil % & # | Immature cell % & # * | ||
| Reticulocyte % & # | Reticulocyte % & # | ||
| IRF | N/A | ||
| * These parameters are | * These parameters are | • These parameters are | |
| for Research Use Only | for Research Use Only | for Research Use Only | |
| (RUO). Not for use in | (RUO). Not for use in | (RUO). Not for use in | |
| diagnostic procedures | diagnostic procedures | diagnostic procedures |
2
| Principles of
| Measurement | |||
|---|---|---|---|
| WBC | Aperture impedance | Aperture Impedance / | |
| Laser Light Scatter- | Aperture impedance | ||
| RBC | Aperture impedance | Aperture Impedance / | |
| Laser Light Scatter | Aperture impedance | ||
| Hgb | Spectrophotometric | Spectrophotometric | Spectrophotometric |
| MCV | Aperture impedance | Aperture Impedance / | |
| Laser Light Scatter | Calculated from Hct | ||
| Hct | Calculated from MCV | Calculated from MCV | Aperture impedance |
| Plt | Aperture impedance | Aperture Impedance / | |
| Laser Light Scatter | Aperture impedance | ||
| Differential | Aperture impedance | ||
| Conductivity, Laser Light | |||
| Scatter (VCS) | Multi- angle Polarized | ||
| Scatter Separation | |||
| (MPASS) | Aperture Impedance | ||
| Light Scattering | |||
| Retics | Laser Light Scatter | Laser Light Scatter | N/A |
| NRBC and | |||
| Non viable | |||
| cells | N/A | Laser Light Scatter | N/A |
| Sample | |||
| Volume | Closed Vial Mode - 185µL | ||
| Open Vial Mode- 125µL | Manual or Automatic | ||
| Modes - 115µL | Open and Closed vial | ||
| modes | |||
| CBC profile - 30 µL | |||
| CBC/DIFF profile - 53µL | |||
| Throughput | Closed and Open Vial | ||
| mode - 75 samples/hour | |||
| Retics - 30 samples/hour | Closed tube mode - | ||
| 115 samples/hour | |||
| Open Tube mode - | |||
| 72 samples/hour | Closed and Open vial | ||
| mode - | |||
| 80 samples/hour |
8.0 Summary of Performance Data:
The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence studies of the COULTER® AcT 5diff AL Hematology Analyzer to products already in commercial distribution.
This summary of safety and effectiveness is being submitted in accordance with the requirements of the Safe Medical Device Act of 1990 and the implementing regulation 21 CFR 807.92.
3
Administrative Information COULTER® AcT™ 5diff Autoloader (AL)
1.0 SUBMITTED BY:
Beckman Coulter, Inc. 11800 SW 147th Avenue MC: 31-B06 Miami, FL 33196-2500 Establishment Registration No. 1061932
Primary Contact: Lourdes Coba, Senior Regulatory Affairs Specialist Telephone: (305) 380-4079 FAX: (305) 380-3618
Secondary Contact: Deborah Herrera, Group Manager, Regulatory Affairs Telephone: (305) 380-4013 FAX: (305) 380-3618
2.0 PRODUCT NAME:
- A. PROPRIETARY NAME: COULTER® AcT™ 5diff Autoloader (AL)
- B. CLASSIFICATION NAME: Automated Differential Cell Counter (21 CFR § 864.5220)
3.0 CLASSIFICATION:
FDA classifies this instrument as a Class II device.
4.0 COMPLIANCE WITH & 514:
Neither performance standards nor other special controls have been promulgated for this test system.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized image of a human figure embracing a three-lined symbol, which represents the department's mission to protect the health of all Americans and provide essential human services.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
APR 1 7 2003
Ms. Lourdes Coba Senior Regulatory Affairs Specialist Beckman Coulter, Inc. 11800 S.W. 147 Avenue M/S 31-Bo6 Miami, FL 33196-2500
Re: K030291
Trade/Device Name: COULTER® AcT™ 5diff Autoloader (AL) Hematology Analyzer Regulation Number: 21 CFR 864.5220 Regulation Name: Automated Differential Cell Counter Regulatory Class: Class II Product Code: GKZ Dated: January 27, 2003 Received: January 28, 2003
Dear Ms. Coba:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
5
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 594-3084. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Steven Putman
Steven I. Gutman, M.D., M.B.A. Director Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
6
510(k) Number (if known): K 030291
COULTER® AcT™ 5diff Autoloader (AL) Hematology Analyzer Device Name:
Indications for Use:
The COULTER® AcT™ 5diff Autoloader (AL) hematology analyzer is a 26parameter, fully automated hematology analyzer, including a five-part leukocyte differential counter, capable of analyzing samples in a closed-vial Autoloader mode or a Manual (Stat) mode (open- or closed-vial).
864.5240 Automated Differential Cell Counter
Identification. An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cvtometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(per 21 CFR 801.109)
OR
Over-the-Counter Use
Optional Format 1-2-96
Spin Bauti
(Division Sign-Off)
Division of Clinical Laboratory Devices K030291
510(k) Number
Beckman Coulter. Inc., Abbreviated 510(k) Notification AcT 5diff AL Section1.doc